γ-Glutamylcysteine Exerts Neuroprotection Effects against Cerebral Ischemia/Reperfusion Injury through Inhibiting Lipid Peroxidation and Ferroptosis. 2022

Ruyi Zhang, and Jianzhen Lei, and Luyao Chen, and Yanan Wang, and Guocui Yang, and Zhimin Yin, and Lan Luo
State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210023, China.

Ferroptosis is a non-apoptotic form of cell death driven by iron-dependent lipid peroxidation. Recent evidence indicates that inhibiting ferroptosis could alleviate cerebral ischemia/reperfusion (CIR) injury. γ-glutamylcysteine (γ-GC), an intermediate of glutathione (GSH) synthesis, can upregulate GSH in brains. GSH is the co-factor of glutathione peroxidase 4 (GPX4), which is the negative regulator of ferroptosis. In this study, we explored the effect of γ-GC on CIR-induced neuronal ferroptosis and brain injury. We found that γ-GC significantly reduced the volume of cerebral infarction, decreased the loss of neurons and alleviated neurological dysfunction induced by CIR in rats. Further observation showed that γ-GC inhibited the CIR-caused rupture of the neuronal mitochondrial outer membrane and the disappearance of cristae, and decreased Fe2+ deposition and lipid peroxidation in rat cerebral cortices. Meanwhile, γ-GC altered the expression of some ferroptosis-related proteins in rat brains. Mechanistically, γ-GC increased the expression of GSH synthetase (GSS) for GSH synthesis via protein kinase C (PKC)ε-mediated activation of nuclear factor erythroid 2-related factor (Nrf2). Our findings suggest that γ-GC not only serves as a raw material but also increases the GSS expression for GSH synthesis against CIR-induced lipid peroxidation and ferroptosis. Our study strongly suggests that γ-GC has potential for treating CIR injury.

UI MeSH Term Description Entries

Related Publications

Ruyi Zhang, and Jianzhen Lei, and Luyao Chen, and Yanan Wang, and Guocui Yang, and Zhimin Yin, and Lan Luo
May 2023, Antioxidants (Basel, Switzerland),
Ruyi Zhang, and Jianzhen Lei, and Luyao Chen, and Yanan Wang, and Guocui Yang, and Zhimin Yin, and Lan Luo
May 2022, Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences,
Ruyi Zhang, and Jianzhen Lei, and Luyao Chen, and Yanan Wang, and Guocui Yang, and Zhimin Yin, and Lan Luo
December 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Ruyi Zhang, and Jianzhen Lei, and Luyao Chen, and Yanan Wang, and Guocui Yang, and Zhimin Yin, and Lan Luo
April 2023, Biological & pharmaceutical bulletin,
Ruyi Zhang, and Jianzhen Lei, and Luyao Chen, and Yanan Wang, and Guocui Yang, and Zhimin Yin, and Lan Luo
April 2021, Journal of molecular neuroscience : MN,
Ruyi Zhang, and Jianzhen Lei, and Luyao Chen, and Yanan Wang, and Guocui Yang, and Zhimin Yin, and Lan Luo
January 2018, Journal of Alzheimer's disease : JAD,
Ruyi Zhang, and Jianzhen Lei, and Luyao Chen, and Yanan Wang, and Guocui Yang, and Zhimin Yin, and Lan Luo
March 2023, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica,
Ruyi Zhang, and Jianzhen Lei, and Luyao Chen, and Yanan Wang, and Guocui Yang, and Zhimin Yin, and Lan Luo
May 2024, Heliyon,
Ruyi Zhang, and Jianzhen Lei, and Luyao Chen, and Yanan Wang, and Guocui Yang, and Zhimin Yin, and Lan Luo
February 1991, Transplantation proceedings,
Ruyi Zhang, and Jianzhen Lei, and Luyao Chen, and Yanan Wang, and Guocui Yang, and Zhimin Yin, and Lan Luo
January 2022, Oxidative medicine and cellular longevity,
Copied contents to your clipboard!